Waystar launches new agentic AI solutions for revenue cycles
These innovations utilize over seven billion transactions to automate claim resolution, enhance clinical documentation, and guide patients through financial obligations.
See the latest news and media coverage for Waystar. We track all announcements, press releases, and industry mentions in real time, all in one place.
Healthcare revenue cycle management software provider
waystar.comLast updated
In short: Waystar reported strong 2026 financial growth, launched agentic AI solutions, and authorized a $200 million share repurchase program.
These innovations utilize over seven billion transactions to automate claim resolution, enhance clinical documentation, and guide patients through financial obligations.
Amit Khanna joins as Chief Product and Technology Officer while Todd Woods assumes the role of Chief Commercial Officer to drive AI and commercial strategy.
Wegner brings 25+ years of finance leadership from public companies. She will help advance Waystar's autonomous revenue cycle vision. Steve Oreskovich remains as advisor after eight years.
She brings experience scaling tech businesses to help advance Waystar's growth strategy and value creation.
According to the same overview from TradersUnion, Waystar stock edged lower on that day, changing hands at USD 25.53 as investors digested the client milestone...
Waystar Holding has an average rating of buy and mean price target of $33.43, according to analysts polled by FactSet.
Software provider Waystar , whose products are used by hospitals and doctors to manage payments, is exploring options including a potential sale that could return...
Waystar Holding Corp. has reported its second-quarter 2026 results, with sales rising to US$319.67 million and net income reaching US$40.87 million, alongside higher earnings per...
Track Waystar and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Waystar and other trending companies.